A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis

Clinical trial NCT00051623 · COMPLETED

Trial details

NCT number: NCT00051623
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Psoriatic

Start date: 2003-05-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.